Available in Packages/Products: PRESENT Complete Podiatric CME Online
The introduction of new antifungal agents in the past decades has transformed the management of topical fungal infections, onychomycosis and invasive mycoses to the point that drug toxicity is no longer the major limiting factor in treatment. Yet, many of these antifungal agents have important limitations in their spectrum of activity, pharmacokinetics, and unique predisposition for pharmacokinetic drug-drug interactions and unusual toxicities associated with long-term use. This presentation reviews key pharmacological aspects of systemic antifungal agents as well as evolving strategies, such as pharmacokinetic-pharmacodynamic optimization and therapeutic drug monitoring, to improve the safety and efficacy of systemic antifungal therapy.
CME (Credits: 1.00)
Complete the 4 steps to earn your CE/CME credit:
PRESENT e-Learning Systems is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. PRESENT e-Learning Systems has approved this activity for a maximum of 1.00 continuing education contact hours
Release Date: 01/22/2025 Expiration Date: 01/22/2028
Robert Smith, DPM, MSc, RPh, SrFNAP
Studying Opioid Harm, Inc (501.3c Non-profit Organization)
Ormond Beach, FL
To view Lectures online, the following specs are required:
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.
---Robert Smith has nothing to disclose.